<code id='56CC3F1CE2'></code><style id='56CC3F1CE2'></style>
    • <acronym id='56CC3F1CE2'></acronym>
      <center id='56CC3F1CE2'><center id='56CC3F1CE2'><tfoot id='56CC3F1CE2'></tfoot></center><abbr id='56CC3F1CE2'><dir id='56CC3F1CE2'><tfoot id='56CC3F1CE2'></tfoot><noframes id='56CC3F1CE2'>

    • <optgroup id='56CC3F1CE2'><strike id='56CC3F1CE2'><sup id='56CC3F1CE2'></sup></strike><code id='56CC3F1CE2'></code></optgroup>
        1. <b id='56CC3F1CE2'><label id='56CC3F1CE2'><select id='56CC3F1CE2'><dt id='56CC3F1CE2'><span id='56CC3F1CE2'></span></dt></select></label></b><u id='56CC3F1CE2'></u>
          <i id='56CC3F1CE2'><strike id='56CC3F1CE2'><tt id='56CC3F1CE2'><pre id='56CC3F1CE2'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:492
          J.P. Morgan office building at night -- JPM health business coverage from STAT
          Adobe

          SAN FRANCISCO — Almost three years ago, the country’s biggest bank unveiled a lofty plan to fix the health care industry’s entrenched problems. It broke off $250 million to stand up a new business unit, Morgan Health, to do so. 

          Today, Morgan Health’s CEO, Dan Mendelson, aided by a newly hired flack, emailed reporters attending that bank’s annual investor confab, the J.P. Morgan Healthcare Conference, asking them for interviews. For the uninitiated, it’s usually the other way around.

          advertisement

          Their message? We’re still here. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Psychedelics group wrestles with new pharma identity
          Psychedelics group wrestles with new pharma identity

          OliviaGoldhill/STATDENVER—Hecouldhavebeenarockstar,areligiousicon,thewayecstaticapplausefromthousand

          read more
          With trial win, GSK could get blood cancer drug back on market
          With trial win, GSK could get blood cancer drug back on market

          JUSTINTALLIS/AFPviaGettyImagesLONDON—TheresurrectionofaGSKbloodcancerdrug—whichthecompanywithdrewfro

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Biotech execs pursue obesity drug boom: ‘It’s the early innings’

          ElaineChenofSTAT,upperleft,talkedaboutobesitydrugswith,clockwise,RaymondStevenofStructureTherapeutic